| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |